Lyell Immunopharma, Inc.
(NASDAQ: LYEL)
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.
25.460
+3.150
(+14.12%)
Range
21.390 - 25.590
(19.64%)
Open
22.480
Previous Close
22.310
Bid Price
2.870
Bid Volume
22
Ask Price
2.960
Ask Volume
12
Volume
92,680
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
